Press Releases
Novaliq GmbH Announces European Market Approval for NovaTears™ OTC
Novaliq GmbH a drug delivery company with a focus on the topical application of ophthalmic technologies for poorly soluble drugs today announced the successful CE...
Press Releases
Investment Group Acquires Metrics Champion Consortium to Drive Adoption and Growth
The Metrics Champion Consortium (MCC) board of directors announced today that the organization has been sold to a group of investors. ...
Press Releases
Oncodesign awarded accreditation of its research center by international association, AAALAC
Oncodesign, a contract research laboratory for the discovery of new anticancer therapies, today announces that its Dijon-based research center has received AAALAC certification. ...
Press Releases
Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain and...
Press Releases
Alize Pharma launches the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2 diabetes
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the...
Press Releases
Impax Laboratories Launches Authorized Generic TRILIPIX® Delayed Release Capsules, 45 mg and 135 mg
Impax Laboratories Inc. today announced that it is commencing shipment of authorized generic TRILIPIX® (fenofibric acid) delayed release capsules 45 mg and 135 mg through...
Press Releases
Tetrahedron announces that Selisseo(R) received a market authorization for use in animal nutrition
Tetrahedron, designing and developing rare natural and synthetic antioxidants for the health nutrition, dermocosmetics and pharmacy sectors, today announces that Selisseo(R) has received marketing authorization...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.